Think Research Corporation (TSXV:THNK) entered into a share purchase agreement to acquire mdBriefCase Inc. from PCP GP, L.P., Jason Flowerday and others for CAD 24.9 million on January 18, 2021. Under the terms of the consideration, the transaction will be settled through issuance of 5.2 million common shares and a cash payment of CAD 1.3 million, subject to working capital and other adjustments on closing. Think Research will assume liabilities of mdBriefCase and refinance it, which will result in the acquisition being on a cash free, debt free basis. mdBriefCase's shareholders will also be entitled to deferred consideration upon the achievement of certain financial milestones during the two-year period following closing of the Transaction, such deferred consideration to be payable in shares of Think Research. mdBriefCase reported revenues of CAD 10.3 million and EBITDA of CAD 0.3 million as at December 31, 2020. mdBriefCase's team will join Think Research. The transaction is subject to customary closing conditions, including approval from the TSXV. The transaction is expected to close in the first quarter of 2021. The transaction represents a meaningful and immediate contributor of revenue and accretive profit. Epic Capital Management will be paid a finder fees of CAD 0.64 million, to be payable as 50% in common stock via issuance of 0.068952 million common shares at CAD 4.65 per share and remaining 50% in cash to the finder of CAD 0.32 million plus HST of CAD 0.08 million on the agreegate finder's fee.